Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 7Genitourinary 7Gastrointestinal 7CNS 7Sarcoma 6Myeloid 6Gynecologic 1Dermatologic 1

Conditions

Ovarian Neoplasms 2Endometrial Neoplasms 2Wilms Tumor 1Sarcoma, Ewing 1Osteosarcoma 1Neuroblastoma 1Neoplasm Metastasis 1Melanoma 1Lymphoma, Non-Hodgkin 1Hepatoblastoma 1Desmoid Tumors 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Filgrastim 7Cyclophosphamide 6Peripheral Blood Stem Cell Transplantation 5Flow Cytometry 5Carboplatin 5Therapeutics 4Psychiatric Rehabilitation 4Immunologic Techniques 4Temozolomide 3Amplified Fragment Length Polymorphism Analysis 3liposomal amphotericin B 2aldesleukin 2Thiotepa 2Radiotherapy 2Polymerase Chain Reaction 2Oxaliplatin 2Ondansetron 2Microarray Analysis 2Methylprednisolone 2Melphalan 2Itraconazole 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Dexamethasone 2Deferasirox 2Caspofungin 2Calcium Dobesilate 2Aprepitant 2Analgesia 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × Phantoms, Imaging × Gynecologic × Clear all
NCT04851119 2026-05-05

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Children's Oncology Group

Phase 1/2 Recruiting
147 enrolled
CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Carcinoma, Hepatocellular, Lymphoma, Non-Hodgkin, Melanoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Ewing, Osteosarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Hepatoblastoma, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡